Cleared Traditional

K852928 - VIROGEN HERPES SLIDE TEST

K852928 is an FDA 510(k) clearance for VIROGEN HERPES SLIDE TEST, manufactured by Armkel, LLC. The device is a Class 2 Microbiology device with product code GQO cleared through the Traditional 510(k) pathway after a 100-day FDA review.

K852928 · Armkel, LLC · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1985
Decision
100d
Days
Class 2
Risk

K852928 is an FDA 510(k) clearance for the VIROGEN HERPES SLIDE TEST. Classified as Antisera, Cf, Herpesvirus Hominis 1,2 (product code GQO), Class II - Special Controls.

Submitted by Armkel, LLC (Cranbury, US). The FDA issued a Cleared decision on October 17, 1985 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3305 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Armkel, LLC devices

FDA 510(k) Submission Details - K852928

510(k) Number K852928 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 09, 1985
Decision Date October 17, 1985
Days to Decision 100 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d faster than avg
Panel avg: 102d · This submission: 100d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GQO Device Classification - Class 2, Special Controls

Product Code GQO Antisera, Cf, Herpesvirus Hominis 1,2
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3305
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - GQO Antisera, Cf, Herpesvirus Hominis 1,2

All 9
Devices cleared under the same product code (GQO) and FDA review panel - the closest regulatory comparables to K852928.
AMIZYME-HSV TYPES 1 & 2 TEST KITS
K842531 · Amico Lab, Inc. · Dec 1985
ANTI-HERPES SIMPLEX VIRUS TYPE 1 OR 2
K842663 · Amico Lab, Inc. · Dec 1985
ENZYGNOST ANTIHERPES SIMPLEX VIRUS
K841245 · Behring Diagnostics, Inc. · Nov 1985
ANTIBODY TO HERPESVIRUS HOMINIS
K791058 · Electro-Nucleonics Laboratories, Inc. · Sep 1979